About Aspira Pathlab & Diagnostics Limited
Data last updated: 10 February 2026
Aspira Pathlab & Diagnostics Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in diagnostic centers and pathology labs, a part of the broader healthcare sector. Incorporated on 03 July 1973, the company has been in operation for over 53 years.
Registered with ROC Mumbai under CIN L85100MH1973PLC289209. Listed on BSE: 540788.
Capital: an authorised share capital of ₹35 Cr and a paid-up capital of ₹15.79 Cr. Formerly known as Utkal Soap Products Ltd and Industrial Gas & Steel Products (India) Limited. It is led by directors including Manas Rajendra Mengar and Nikunj Velji Mange.
Last AGM: 26 September 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.39 Cr, a growth of 64% compared to the previous year.
The company has a workforce of approximately 70 employees as per the latest available data.
The company is associated with 1 brand - Aspira Diagnostics. As per MCA filings, the company has satisfied charges of ₹6.22 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aspiradiagnostics.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Apps
-
Registered AddressFlat No.2 R.D. Shah Bldg Shraddhanand Road Opp. Ghatkopar Railway Station Ghatkopa, R (West), Mumbai, Maharashtra, India – 400086
-
IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Aspira Pathlab & Diagnostics Limited
Aspira Pathlab & Diagnostics Limited has undergone 3 name changes throughout its history. The company was previously known as Utkal Soap Products Ltd, Industrial Gas & Steel Products (India) Limited, and Utkal Soap Products Limited. The current legal name is Aspira Pathlab & Diagnostics Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Aspira Pathlab & Diagnostics Limited | Current |
| Utkal Soap Products Ltd | Previous |
| Industrial Gas & Steel Products (India) Limited | Previous |
| Utkal Soap Products Limited | Previous |
CIN History of Aspira Pathlab & Diagnostics Limited
Aspira Pathlab & Diagnostics Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L85100MH1973PLC289209, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85100MH1973PLC289209 | Current |
| L51909WB1973PLC028878 | Previous |
| L85100WB1973PLC028878 | Previous |
Associated Brands with Aspira Pathlab & Diagnostics Limited
Aspira Pathlab & Diagnostics Limited operates one associated brand: Aspira Diagnostics. These brands represent Aspira Pathlab & Diagnostics Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pathology lab services are operated through a chain of facilities. | aspiradiagnostics.com |
Competitors & Alternatives of Aspira Pathlab & Diagnostics Limited
Brands and companies operating in the same space as Aspira Pathlab & Diagnostics Limited include Dr Lal PathLabs, Redcliffe Labs, Metropolis India and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Dr Lal PathLabs
|
Chain of pathology and radiology labs | Gurugram, India, India | 1949 |
Redcliffe Labs
|
Home-based diagnostic tests are booked via an online platform. | Noida, India, India | 2018 |
Metropolis India
|
Diagnostic centers are operated as a nationwide chain. | Mumbai, India, India | 1981 |
Orange health
|
At-home diagnostic tests are booked and collected by phlebotomists. | Bengaluru, India, India | 2020 |
Agilus Diagnostics
|
Leading diagnostic chain providing quality blood test and full body checkup services | Gurugram, India, India | 1995 |
Apollo Diagnostics
|
Provides pathology lab tests, health check packages, and home sample collection. | Hyderabad, India, India | 2015 |
Sterling Accuris Diagnostics
|
Pathology diagnostic services are offered via a chain of labs. | Ahmedabad, India, India | 2015 |
Airmed
|
Provider of a chain of diagnostic labs | Ahmedabad, India, India | 2016 |
Business Activity of Aspira Pathlab & Diagnostics Limited
Aspira Pathlab & Diagnostics Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including medical and dental practice, nursing, pathology, blood bank services, etc..
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. | ********* |
Auditor Details of Aspira Pathlab & Diagnostics Limited
Aspira Pathlab & Diagnostics Limited is audited by Sarda Soni Associates LLP (ICAI peer reviewed, certificate valid till 2026-10-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Sarda Soni Associates LLP (ICAI peer reviewed, certificate valid till 2026-10-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Aspira Pathlab & Diagnostics Limited
Aspira Pathlab & Diagnostics Limited is currently managed by 7 directors, with 30 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Manas Rajendra Mengar
Also directs:
Aspira Pathlab & Diagnostics Limited
|
Director | 12 Aug 2023 | 2 Years 10 Months | Current |
| Nikunj Velji Mange | Director | 29 Aug 2020 | 5 Years 10 Months | Current |
|
Haseeb Ahmad Drabu
Also directs:
Aspira Pathlab & Diagnostics Limited, Essar Power Limited, Essar Ports & Logistics Limited and 5 more
|
Director | 27 Oct 2018 | 7 Years 8 Months | Current |
| Pankaj Jashwant Shah | Managing Director | 01 Aug 2016 | 9 Years 11 Months | Current |
|
Kiran Raghavendra Awasthi
Also directs:
Aspira Pathlab & Diagnostics Limited, Raj Oil Mills Limited
|
Additional Director | 12 Nov 2025 | 0 Years 7 Months | Current |
Financials of Aspira Pathlab & Diagnostics Limited FY 2026 filings available
Aspira Pathlab & Diagnostics Limited reported revenue of ₹24.98 Cr (up 13.56% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹24.98 Cr | ₹22 Cr | ₹13.2 Cr | ₹14.46 Cr | ₹19.54 Cr | ₹15.21 Cr | ₹8.42 Cr | ₹7.64 Cr |
| Other Income | ₹51.59 Lakh | ₹38.89 Lakh | ₹42.11 Lakh | ₹32.09 Lakh | ₹10.29 Lakh | ₹20.38 Lakh | ₹28.8 Lakh | ₹25.32 Lakh |
| Total Income | ₹25.5 Cr | ₹22.39 Cr | ₹13.63 Cr | ₹14.78 Cr | ₹19.64 Cr | ₹15.41 Cr | ₹8.7 Cr | ₹7.89 Cr |
| Cost of Materials Consumed | ₹4.52 Cr | ₹3.7 Cr | ₹2.62 Cr | ₹2.5 Cr | ₹3.14 Cr | ₹2.63 Cr | ₹1.99 Cr | ₹2.26 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹8.78 Cr | ₹7.33 Cr | ₹6.2 Cr | ₹5.59 Cr | ₹5.02 Cr | ₹4.03 Cr | ₹4.95 Cr | ₹4.47 Cr |
| Finance Costs | ₹38.94 Lakh | ₹34.74 Lakh | ₹36.77 Lakh | ₹41.72 Lakh | ₹37.27 Lakh | ₹89.15 Lakh | ₹1.01 Cr | ₹96.07 Lakh |
| Depreciation & Amortisation | ₹1.54 Cr | ₹1.49 Cr | ₹1.54 Cr | ₹1.59 Cr | ₹1.64 Cr | ₹1.44 Cr | ₹1.66 Cr | ₹1.23 Cr |
| Other Expenses | ₹10.22 Cr | ₹7.45 Cr | ₹5.57 Cr | ₹4.77 Cr | ₹5.02 Cr | ₹5.03 Cr | ₹3.34 Cr | ₹4.15 Cr |
| Total Expenses | ₹25.45 Cr | ₹20.32 Cr | ₹16.3 Cr | ₹14.87 Cr | ₹15.19 Cr | ₹14.03 Cr | ₹12.95 Cr | ₹13.07 Cr |
| Profit Before Exceptional Items & Tax | ₹5.13 Lakh | ₹2.07 Cr | -₹2.67 Cr | -₹8.87 Lakh | ₹4.46 Cr | ₹1.38 Cr | -₹4.24 Cr | -₹5.18 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹5.13 Lakh | ₹2.07 Cr | -₹2.67 Cr | -₹8.87 Lakh | ₹4.46 Cr | ₹1.38 Cr | -₹4.24 Cr | -₹5.18 Cr |
| Total Tax Expense | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Profit | ₹5.13 Lakh | ₹2.07 Cr | -₹2.67 Cr | -₹8.87 Lakh | ₹4.46 Cr | ₹1.38 Cr | -₹4.24 Cr | -₹5.18 Cr |
| Other Comprehensive Income | ₹6.12 Lakh | ₹4,000 | ₹6.51 Lakh | ₹4.96 Lakh | ₹1.55 Lakh | ₹13.27 Lakh | -₹1 Lakh | ₹97,000 |
| Total Comprehensive Income | ₹11.25 Lakh | ₹2.07 Cr | -₹2.61 Cr | -₹3.91 Lakh | ₹4.47 Cr | ₹1.51 Cr | -₹4.25 Cr | -₹5.17 Cr |
| EBITDA (computed) | ₹1.98 Cr | ₹3.91 Cr | -₹76.57 Lakh | ₹1.91 Cr | ₹6.47 Cr | ₹3.72 Cr | -₹1.57 Cr | -₹2.99 Cr |
| Basic EPS | ₹0.05 | ₹2.01 | ₹2.60 | ₹-0.09 | ₹4.33 | ₹1.59 | ₹-4.56 | ₹-6.31 |
| Diluted EPS | ₹0.05 | ₹2.01 | ₹2.60 | ₹-0.09 | ₹4.33 | ₹1.59 | ₹-4.95 | ₹-7.40 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹18.51 Cr | ₹17.51 Cr | ₹14.71 Cr | ₹17.34 Cr | ₹18.14 Cr | ₹11.78 Cr | ₹14.34 Cr | ₹14.8 Cr |
| Non-current Assets | ₹13.92 Cr | ₹12.15 Cr | ₹10.35 Cr | ₹11.49 Cr | ₹10.99 Cr | ₹7.9 Cr | ₹11.05 Cr | ₹12.5 Cr |
| Current Assets | ₹4.59 Cr | ₹5.36 Cr | ₹4.36 Cr | ₹5.86 Cr | ₹7.14 Cr | ₹3.88 Cr | ₹3.29 Cr | ₹2.3 Cr |
| Property, Plant & Equipment | ₹3.88 Cr | ₹3.86 Cr | ₹4.12 Cr | ₹5.31 Cr | ₹6.82 Cr | ₹4.96 Cr | ₹5.03 Cr | ₹6.19 Cr |
| Inventories | ₹69.72 Lakh | ₹51.13 Lakh | ₹44.72 Lakh | ₹39.89 Lakh | ₹40.45 Lakh | ₹36.67 Lakh | ₹27.65 Lakh | ₹28.01 Lakh |
| Trade Receivables | ₹1.73 Cr | ₹2.35 Cr | ₹2.24 Cr | ₹2.34 Cr | ₹4.49 Cr | ₹1.7 Cr | ₹60.46 Lakh | ₹79.61 Lakh |
| Cash & Equivalents | ₹1.26 Cr | ₹1.75 Cr | ₹80.38 Lakh | ₹56.66 Lakh | ₹1.35 Cr | ₹1.19 Cr | ₹9.65 Lakh | ₹9.64 Lakh |
| Equity (Net Worth) | ₹12.23 Cr | ₹12.22 Cr | ₹10.14 Cr | ₹12.75 Cr | ₹12.79 Cr | ₹8.31 Cr | ₹3.8 Cr | ₹5.19 Cr |
| Equity Share Capital | ₹10.29 Cr | ₹10.29 Cr | ₹10.29 Cr | ₹10.29 Cr | ₹10.29 Cr | ₹10.29 Cr | ₹9.29 Cr | ₹8.19 Cr |
| Borrowings (Non-current) | ₹1.35 Cr | ₹1.21 Cr | ₹1.08 Cr | ₹96.18 Lakh | ₹85.87 Lakh | ₹76.67 Lakh | ₹4.55 Cr | ₹4.78 Cr |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹2.32 Cr | ₹1.96 Cr |
| Total Debt (computed) | ₹1.35 Cr | ₹1.21 Cr | ₹1.08 Cr | ₹96.18 Lakh | ₹85.87 Lakh | ₹76.67 Lakh | ₹6.87 Cr | ₹6.75 Cr |
| Current Liabilities | ₹3.11 Cr | ₹2.37 Cr | ₹2.07 Cr | ₹1.58 Cr | ₹1.79 Cr | ₹2.01 Cr | ₹5.12 Cr | ₹4.21 Cr |
| Total Liabilities | ₹6.27 Cr | ₹5.3 Cr | ₹4.57 Cr | ₹4.59 Cr | ₹5.35 Cr | ₹3.46 Cr | ₹10.53 Cr | ₹9.61 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹1.45 Cr | ₹1.88 Cr | ₹1.05 Cr | -₹1.21 Lakh | ₹2.03 Cr |
| Investing Cash Flow | -₹80.43 Lakh | ₹6.58 Lakh | ₹13.83 Lakh | ₹15.94 Lakh | -₹51.23 Lakh |
| Financing Cash Flow | -₹1.14 Cr | -₹99.41 Lakh | -₹95.41 Lakh | -₹93.5 Lakh | -₹1.35 Cr |
| Capital Expenditure | ₹69.57 Lakh | ₹34.43 Lakh | ₹26.18 Lakh | ₹13.13 Lakh | ₹59.86 Lakh |
| Free Cash Flow (computed) | ₹75.79 Lakh | ₹1.53 Cr | ₹79.12 Lakh | -₹14.34 Lakh | ₹1.43 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹48.79 Lakh | ₹94.86 Lakh | ₹23.72 Lakh | -₹78.77 Lakh | ₹16.67 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹6.52 Cr | ₹5.12 Cr | ₹8.09 Cr | ₹5.25 Cr | ₹5.78 Cr | ₹5.41 Cr | ₹6.18 Cr | ₹4.64 Cr |
| Other Income | ₹13.92 Lakh | ₹12.95 Lakh | ₹13.95 Lakh | ₹10.77 Lakh | ₹13.04 Lakh | ₹8.86 Lakh | ₹7.58 Lakh | ₹9.18 Lakh |
| Total Income | ₹6.66 Cr | ₹5.25 Cr | ₹8.23 Cr | ₹5.36 Cr | ₹5.91 Cr | ₹5.5 Cr | ₹6.25 Cr | ₹4.73 Cr |
| Cost of Materials Consumed | ₹1.22 Cr | ₹1.12 Cr | ₹1.28 Cr | ₹89.6 Lakh | ₹86.95 Lakh | ₹84.89 Lakh | ₹1.1 Cr | ₹88.03 Lakh |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹2.29 Cr | ₹2.45 Cr | ₹2.15 Cr | ₹1.89 Cr | ₹1.94 Cr | ₹1.97 Cr | ₹1.75 Cr | ₹1.66 Cr |
| Finance Costs | ₹9.97 Lakh | ₹9.81 Lakh | ₹9.76 Lakh | ₹9.4 Lakh | ₹9.32 Lakh | ₹9.41 Lakh | ₹7.89 Lakh | ₹8.12 Lakh |
| Depreciation & Amortisation | ₹39.54 Lakh | ₹38.23 Lakh | ₹39.55 Lakh | ₹36.52 Lakh | ₹36.74 Lakh | ₹38.59 Lakh | ₹36.39 Lakh | ₹37.66 Lakh |
| Other Expenses | ₹3.35 Cr | ₹2.76 Cr | ₹2.47 Cr | ₹1.64 Cr | ₹1.91 Cr | ₹1.82 Cr | ₹1.97 Cr | ₹1.75 Cr |
| Total Expenses | ₹7.35 Cr | ₹6.81 Cr | ₹6.4 Cr | ₹4.89 Cr | ₹5.18 Cr | ₹5.12 Cr | ₹5.26 Cr | ₹4.75 Cr |
| Profit Before Exceptional Items & Tax | -₹68.91 Lakh | -₹1.56 Cr | ₹1.84 Cr | ₹46.94 Lakh | ₹72.33 Lakh | ₹37.66 Lakh | ₹99.03 Lakh | -₹1.67 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹68.91 Lakh | -₹1.56 Cr | ₹1.84 Cr | ₹46.94 Lakh | ₹72.33 Lakh | ₹37.66 Lakh | ₹99.03 Lakh | -₹1.67 Lakh |
| Total Tax Expense | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Profit | -₹68.91 Lakh | -₹1.56 Cr | ₹1.84 Cr | ₹46.94 Lakh | ₹72.33 Lakh | ₹37.66 Lakh | ₹99.03 Lakh | -₹1.67 Lakh |
| Other Comprehensive Income | ₹6.12 Lakh | ₹0 | ₹0 | ₹0 | ₹4,000 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹62.79 Lakh | -₹1.56 Cr | ₹1.84 Cr | ₹46.94 Lakh | ₹72.37 Lakh | ₹37.66 Lakh | ₹99.03 Lakh | -₹1.67 Lakh |
| EBITDA (computed) | -₹19.4 Lakh | -₹1.08 Cr | ₹2.33 Cr | ₹92.86 Lakh | ₹1.18 Cr | ₹85.66 Lakh | ₹1.43 Cr | ₹44.11 Lakh |
| Basic EPS | ₹-0.67 | ₹-1.52 | ₹1.78 | ₹0.46 | ₹0.70 | ₹0.37 | ₹0.96 | ₹0.02 |
| Diluted EPS | ₹-0.67 | ₹-1.52 | ₹1.78 | ₹0.46 | ₹0.70 | ₹0.37 | ₹0.96 | ₹0.02 |
| Metrics | FY 2025 |
|---|---|
| Revenue from Operations | ₹22 Cr |
| Other Income | ₹38.89 Lakh |
| Total Income | ₹22.39 Cr |
| Cost of Materials Consumed | ₹3.7 Cr |
| Purchases of Stock-in-Trade | ₹0 |
| Changes in Inventories | ₹0 |
| Employee Benefit Expense | ₹7.33 Cr |
| Finance Costs | ₹34.74 Lakh |
| Depreciation & Amortisation | ₹1.49 Cr |
| Other Expenses | ₹7.45 Cr |
| Total Expenses | ₹20.32 Cr |
| Profit Before Exceptional Items & Tax | ₹2.07 Cr |
| Exceptional Items | -₹5 Lakh |
| Profit Before Tax | ₹2.02 Cr |
| Total Tax Expense | ₹0 |
| Net Profit | ₹2.02 Cr |
| attributable to Owners | ₹0 |
| attributable to NCI | ₹0 |
| Other Comprehensive Income | ₹4,000 |
| Total Comprehensive Income | ₹2.02 Cr |
| EBITDA (computed) | ₹3.91 Cr |
| Basic EPS | ₹1.97 |
| Diluted EPS | ₹1.97 |
| Metrics | FY 2025 |
|---|---|
| Total Assets | ₹17.46 Cr |
| Non-current Assets | ₹12.1 Cr |
| Current Assets | ₹5.36 Cr |
| Property, Plant & Equipment | ₹3.86 Cr |
| Inventories | ₹51.13 Lakh |
| Trade Receivables | ₹2.35 Cr |
| Cash & Equivalents | ₹1.75 Cr |
| Equity (Net Worth) | ₹12.17 Cr |
| Equity Share Capital | ₹10.29 Cr |
| Borrowings (Non-current) | ₹1.21 Cr |
| Borrowings (Current) | ₹0 |
| Total Debt (computed) | ₹1.21 Cr |
| Current Liabilities | ₹2.37 Cr |
| Total Liabilities | ₹5.3 Cr |
| Metrics | FY 2025 |
|---|---|
| Operating Cash Flow | ₹1.83 Cr |
| Investing Cash Flow | ₹11.57 Lakh |
| Financing Cash Flow | -₹99.42 Lakh |
| Capital Expenditure | ₹34.43 Lakh |
| Free Cash Flow (computed) | ₹1.48 Cr |
| Dividends Paid | ₹0 |
| Net Change in Cash | ₹94.86 Lakh |
| Metrics | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|
| Revenue from Operations | ₹5.25 Cr | ₹5.78 Cr | ₹5.41 Cr | ₹6.18 Cr | ₹4.64 Cr |
| Other Income | ₹10.77 Lakh | ₹13.05 Lakh | ₹8.86 Lakh | ₹7.58 Lakh | ₹9.18 Lakh |
| Total Income | ₹5.36 Cr | ₹5.91 Cr | ₹5.5 Cr | ₹6.25 Cr | ₹4.73 Cr |
| Cost of Materials Consumed | ₹89.6 Lakh | ₹86.95 Lakh | ₹84.89 Lakh | ₹1.1 Cr | ₹88.03 Lakh |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹1.89 Cr | ₹1.94 Cr | ₹1.97 Cr | ₹1.75 Cr | ₹1.66 Cr |
| Finance Costs | ₹9.4 Lakh | ₹9.31 Lakh | ₹9.41 Lakh | ₹7.89 Lakh | ₹8.12 Lakh |
| Depreciation & Amortisation | ₹36.52 Lakh | ₹36.74 Lakh | ₹38.59 Lakh | ₹36.39 Lakh | ₹37.66 Lakh |
| Other Expenses | ₹1.64 Cr | ₹1.91 Cr | ₹1.82 Cr | ₹1.97 Cr | ₹1.75 Cr |
| Total Expenses | ₹4.89 Cr | ₹5.18 Cr | ₹5.12 Cr | ₹5.26 Cr | ₹4.75 Cr |
| Profit Before Exceptional Items & Tax | ₹46.94 Lakh | ₹72.34 Lakh | ₹37.66 Lakh | ₹99.03 Lakh | -₹1.67 Lakh |
| Exceptional Items | ₹0 | -₹4.28 Lakh | -₹7.05 Lakh | -₹5,000 | ₹0 |
| Profit Before Tax | ₹46.94 Lakh | ₹68.06 Lakh | ₹30.61 Lakh | ₹98.98 Lakh | -₹1.67 Lakh |
| Total Tax Expense | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Profit | ₹42.15 Lakh | ₹68.06 Lakh | ₹30.61 Lakh | ₹98.98 Lakh | ₹4.71 Lakh |
| attributable to Owners | - | ₹0 | - | ₹0 | ₹0 |
| attributable to NCI | - | ₹0 | - | ₹0 | ₹0 |
| Other Comprehensive Income | ₹0 | ₹4,000 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹42.15 Lakh | ₹68.1 Lakh | ₹30.61 Lakh | ₹98.98 Lakh | ₹4.71 Lakh |
| EBITDA (computed) | ₹92.86 Lakh | ₹1.18 Cr | ₹85.66 Lakh | ₹1.43 Cr | ₹44.11 Lakh |
| Basic EPS | ₹0.41 | ₹0.66 | ₹0.30 | ₹0.96 | ₹0.05 |
| Diluted EPS | ₹0.41 | ₹0.66 | ₹0.30 | ₹0.96 | ₹0.05 |
Shareholding Pattern of Aspira Pathlab & Diagnostics Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 18.39%, retail and other public shareholders hold 81.61% of Aspira Pathlab & Diagnostics Limited. The company had 1,769 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 18.39% | 18.39% | 18.39% | 18.39% | 18.39% | 18.55% |
| Public | 81.61% | 81.61% | 81.61% | 81.61% | 81.61% | 81.45% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 18.39% | 18.39% | 18.72% |
| Public | 81.61% | 81.61% | 81.28% |
| Promoter change (YoY, %pts) | +0.00 | -0.33 | - |
Charges & Borrowings of Aspira Pathlab & Diagnostics Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jul 2020 | Hdfc Bank Limited | ₹96.8 Lakh | Satisfied |
| 04 Jun 2018 | Hdfc Bank Limited | ₹50 Lakh | Satisfied |
| 07 Dec 2016 | Hdfc Bank Limited | ₹4.75 Cr | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Aspira Pathlab & Diagnostics Limited
Aspira Pathlab & Diagnostics Limited has a workforce of 70 employees as of Dec 20, 2024.
Employee Count & EPFO Data of Aspira Pathlab & Diagnostics Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Aspira Pathlab & Diagnostics Limited
GSTIN & GST Filing Data of Aspira Pathlab & Diagnostics Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Aspira Pathlab & Diagnostics Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Aspira Pathlab & Diagnostics Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Aspira Pathlab & Diagnostics Limited
MSME Payment Delays by Aspira Pathlab & Diagnostics Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Aspira Pathlab & Diagnostics Limited
Subsidiaries & Group Companies of Aspira Pathlab & Diagnostics Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Aspira Pathlab & Diagnostics Limited with ownership details.
MCA Filings & Documents of Aspira Pathlab & Diagnostics Limited
MCA Filings & Documents of Aspira Pathlab & Diagnostics Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Aspira Pathlab & Diagnostics Limited
Recent News on Aspira Pathlab & Diagnostics Limited
Frequently Asked Questions about Aspira Pathlab & Diagnostics Limited
Aspira Pathlab & Diagnostics Limited is an active public limited company in the healthcare sector based in Mumbai, Maharashtra, India. It was incorporated on 03 July 1973 (53+ years old) and is registered under CIN L85100MH1973PLC289209. Listed on BSE: 540788. The company has 70 employees.
Aspira Pathlab & Diagnostics Limited reported revenue of ₹22.39 Cr for FY 2025 (up 64.00% YoY).
The current directors of Aspira Pathlab & Diagnostics Limited are:
- Manas Rajendra Mengar
- Pankaj Jashwant Shah
- Nikunj Velji Mange
- Haseeb Ahmad Drabu
- Balkrishna Subhash Talawadekar
- Krupali Kirti Kumar Shah
- Kiran Raghavendra Awasthi
The primary industry of Aspira Pathlab & Diagnostics Limited is healthcare. The company specifically operates in diagnostic centers and pathology labs. The company is currently active in this sector.
Yes. Aspira Pathlab & Diagnostics Limited is listed on BSE with code 540788.
Aspira Pathlab & Diagnostics Limited can be reached at the registered office: Flat No.2 R.D. Shah Bldg Shraddhanand Road Opp. Ghatkopar Railway Station Ghatkopa, R West, Mumbai, Maharashtra, India – 400086, or through the website aspiradiagnostics.com.